MedTrace Logo

The HypoVoice Study

NCT05569876 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 7

Last updated 2023-03-10

No results posted yet for this study

Summary

The HypoVoice study aims at identifying potential vocal biomarkers associated with hypoglycemia to pave the way towards a voice-based hypoglycemia detection approach.

Conditions

Interventions

OTHER

Controlled hypoglycemic state

Voice sampling is performed in different glycemic states (euglycemia and hypoglycemia).

Sponsors & Collaborators

  • Idiap Research Institute

    collaborator UNKNOWN

  • CSEM Centre Suisse d'Electronique et de Microtechnique SA

    collaborator UNKNOWN

  • Ludwig-Maximilians - University of Munich

    collaborator OTHER

  • Insel Gruppe AG, University Hospital Bern

    lead OTHER

Principal Investigators

  • Christoph Stettler, Prof. MD · Department of Diabetes, Endocrinology, Nutritional Medicine and Metabolism, Bern, Switzerland

Study Design

Allocation
NA
Purpose
OTHER
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-11-11
Primary Completion
2023-01-31
Completion
2023-01-31

Countries

  • Switzerland

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05569876 on ClinicalTrials.gov